Congress Must Protect Inspector General from Retaliation, Bullying
April 27: Patients Over Pharma calls for Congress to protect HHS Inspector General from Trump bullying and intimidation May…
Read moreApril 27: Patients Over Pharma calls for Congress to protect HHS Inspector General from Trump bullying and intimidation May…
Read moreTonight, President Trump will presumably stand in the shadow of Honest Abe and repeat the false claims that the past few months — which have seen more than 1 million confirmed cases of COVID-19…
Read moreNew polling aligns with Patients Over Pharma’s push for Congress to prioritize drug affordability in upcoming COVID-19 legislation Only 9% believe Big Pharma claim that patient protections and affordability guarantees…
Read moreREAD: Patients Over Pharma op-ed laying out Coronavirus Drug Accountability and Transparency Plan Washington, DC – Today, Accountable.US president Kyle Herrig released additional details of Patients Over Pharma’s push for Congress to include strong…
Read moreAxios: “Jaguar Health more than tripled the price of its lone FDA-approved drug, right after asking the federal government to expand the use of its drug to coronavirus patients”…
Read moreWASHINGTON, D.C. – The New York Times reported yesterday that the Trump administration’s removal of a career official from his role at the Department of Health and Human…
Read moreREVOLVING DOOR: Drug company lobbyists included former Trump officials Washington, DC – Today, Patients Over Pharma released a new analysis of lobbying disclosures that showed that major pharmaceutical companies and their trade…
Read moreNY Times: “Among those fighting the orders are FreedomWorks…used their social media accounts and text and email lists to spread the word about protests across the country.” “FreedomWorks…
Read moreTHE HILL: “While much attention has been placed on the desperate hunt for more ventilators, the machines are useless unless they are accompanied by drugs to sedate…
Read moreNEW YORK TIMES: “If hydroxychloroquine becomes an accepted treatment, several pharmaceutical companies stand to profit, including shareholders and senior executives with connections to the president.” NYT: “…the president’s assertiveness in…
Read more“Gov. Mike DeWine…called President Trump over the weekend to ask a favor…Trump called up FDA Commissioner Stephen Hahn. ‘And within a very short period of time…they got the approval.’”…
Read moreOrphan drug status intended for rare diseases, gives Big Pharma giant Gilead exclusive rights, blocks generic versions for seven years Gilead’s former top lobbyist now top Trump advisor on Coronavirus…
Read more